Change of Guard at Parkway Pantai India

IMT News Desk
IMT News Desk
· 2 min read
New General Manager

Ramesh Krishnan, Chief Executive Officer, India Operations Division, Parkway Pantai will step down on May1, 2018   and Dr Ajay Bakshi, former CEO, Manipal Hospitals will take over as CEO.

Parkway Pantai is one of Asia’s largest integrated private healthcare groups operating in Singapore, Malaysia, India, China, Brunei and United Arab Emirates. For over 40 years, its Mount Elizabeth, Gleneagles, Pantai and Parkway brands have established themselves as the region’s best known brands in private healthcare, synonymous with best – in – class patient experience and outcomes.

It is part of IHH Healthcare, the world’s second largest healthcare group by market capitalisation. IHH operates more than 10,000 licensed beds across 50 hospitals in 10 countries worldwide, offering the full spectrum of integrated healthcare services from clinics to hospitals to Quaternary are and a wide range of ancillary services including medical education.

Ramesh Krishnan, current Chief Executive Officer, India Operations Division, Parkway Pantai says, “Personally it has been a very fulfilling five  years for me at Parkway Pantai in building the franchise across India. Today, India is one of our home markets, alongside Malaysia and Singapore. I am proud to hand over the baton to a highly qualified and passionate professional of Ajay’s calibre. He can steer the India operations through its next phase of growth and consolidation, and continue leading an excellent team which I have had the good fortune to put together.”

Dr Ajay Bakshi, Chief Executive Officer-Designate, India Operations Division, Parkway Pantai, says, “I am privileged to be invited to lead Parkway Pantai’s India Operations.  I thank Ramesh for laying the groundwork so that I have a good foundation to build on our future developments in India. It’s an exciting journey ahead because of the tremendous growth potential for healthcare in India. We hope to serve and delight more patients through innovation for best clinical outcomes as well as safety, service and quality excellence.”

Read Next

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability
News
May 18, 2026

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

Annora Pharma, the formulations subsidiary of Hetero Group, has expanded its collaboration with AltiusHub. The company is deploying AltiusHub’s AI-native serialization, track & trace and regulatory compliance platform across its export operations. The deployment is designed to improve serialization efficiency by up to 45%. It will also strengthen operational visibility across Annora Pharma’s global supply […]
Article by: IMT News Desk
WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation
News
May 18, 2026

WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation

The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has announced collaboration with Time Medical International Ventures (India) Pvt. Ltd (Time Medical India)., a wholly owned subsidiary of Fischer Medical Ventures Limited, marking a significant milestone in advancing innovation in global neurosurgical care. This marks the first time the Committee has formally partnered […]
Article by: IMT News Desk
National AI Doctors Mission launches in New Delhi: How AI will change Indian healthcare
News
May 18, 2026

National AI Doctors Mission launches in New Delhi: How AI will change Indian healthcare

The National AI Doctors Mission (NAIDM) has been formally launched in New Delhi, marking a major step toward integrating artificial intelligence into everyday clinical practice across India’s public and private healthcare system. The initiative, led by Medical Dialogues in collaboration with the National Medical Forum, aims to make AI “useful and usable” for frontline doctors rather than […]
Article by: IMT News Desk
Gland Pharma rallies on upbeat Q4; profit soars 97% YoY to ₹367 crore
News
May 18, 2026

Gland Pharma rallies on upbeat Q4; profit soars 97% YoY to ₹367 crore

Gland Pharma shares extended gains in the capital markets after the company posted a standout Q4 performance, with consolidated net profit jumping 97% year‑on‑year to ₹367 crore, riding on a sharp improvement in operating leverage and a strong base‑business showing in the US. Revenue for the quarter rose 22% YoY to ₹1,743 crore, while EBITDA surged 48% YoY […]
Article by: IMT News Desk